Prostatis Group’s Charles Schwab SCHW Stock Holding History

Prostatis Group’s Portfolio SCHW Stock Details SCHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,032	Closed	-$379K	–	199
2026 Q1	$379K	Sell	4,032 -15	-0.4%	-$1.47K	0.1%	117
2025 Q4	$404K	Buy	+4,047	New	+$384K	0.1%	114

Other funds holding SCHW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Prostatis Group's SCHW Position: Q2 2026 in Review

Prostatis Group sold out of Charles Schwab (SCHW) in Q2 2026, closing a stake of 4,032 shares — an estimated $379K sold.

Prostatis Group first reported a position in SCHW in Q4 2025 and held it in 2 quarters. The position peaked at $404K in Q4 2025. 2,310 funds tracked by Wall St. Rank hold SCHW as of Q2 2026.

Prostatis Group reported no remaining Charles Schwab position as of Q2 2026 after selling out during the quarter.
Prostatis Group sold 4,032 Charles Schwab shares in Q2 2026, an estimated $379K.
Prostatis Group first reported a position in Charles Schwab in Q4 2025 and held it in 2 quarters.
Prostatis Group's Charles Schwab position peaked at $404K in Q4 2025.
2,310 funds tracked by Wall St. Rank held Charles Schwab as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.